Inventor
WHITE CATHERINE M
US9 patents
⚠️ This page may combine multiple inventors who share the name “WHITE CATHERINE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
8 patentsUS9657033B2May 23, 2017
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
MERCK SHARP & DOHME20 citations91
US10221146B2Mar 5, 2019
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations83
US9809561B2Nov 7, 2017
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME8 citations83
US10377768B2Aug 13, 2019
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations82
US11319283B2May 3, 2022
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US11111232B2Sep 7, 2021
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US10745364B2Aug 18, 2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME0 citations51
US11319295B2May 3, 2022
Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations50